Transcutaneous auricular vagus nerve stimulation improves depressive-like behaviors in CUMS rats through regulation of gut microbiome, serum metabolites, and immune factors
Frontiers in Microbiology · 01.07.2026 · 17
DOI: 10.3389/fmicb.2026.1820578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 01.07.2026. Verfasst von Chaoren Tan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China. Die Arbeit nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Depression is associated with microbiota-gut-brain (MGB) axis dysregulation. Transcutaneous auricular vagus nerve stimulation (taVNS) has shown antidepressant effects and modulated gut microbiota, but its potential to alleviate depression specifically via modulation of the MGB axis remains largely unexplored.
Methods
Rats subjected to chronic unpredictable mild stress (CUMS) received taVNS for 3 weeks. We assessed depressive-like behaviors, gut microbiota, plasma metabolism, and inflammatory marker levels. Pearson correlation analyses examined relationships among these factors. Results taVNS significantly improved depressive behaviors in CUMS rats. It shifted gut microbiota composition, enriching beneficial Lactobacillus murinus , Bifidobacterium animalis , and Prevotellaceae while reducing harmful Bacteroidales and Romboutsia. Metabolomics revealed taVNS modulated plasma metabolism, especially metabolism of cofactor/vitamin, sphingolipid metabolism, amino and organic acid metabolism, increasing the levels of indole-3-lactic acid (ILA), riboflavin, sphingosine-1-phosphate (S1P), sphinganine-1-phosphate (Sa1P) and sphingosine (SP), and creatine. taVNS also reduced blood, hippocampus and prefrontal cortex inflammation. Pearson correlation analysis showed that alleviation of depressive behaviors positively correlated with Lactobacillus murinus , Bifidobacterium animalis , and plasma ILA, riboflavin, S1P, Sa1P, SP, and creatine and all these parameters inversely associated with pro-inflammatory factors.
Conclusion
These findings indicate that taVNS may alleviate depression by enriching Lactobacillus murinus and Bifidobacterium animalis to enhance biosynthesis of microbiota-derived metabolites (ILA, riboflavin) and modulate host plasma metabolites (S1P, Sa1P, SP, creatine), thereby attenuating systemic and neuroinflammatory processes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China.
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- Department of Traditional Chinese Medicine, National Center for Children's Health, Beijing Children's Hospital, Capital Medical University, Beijing, China.
Zitieren
APA
Tan, C., Qiao, M., Ma, Y., Wang, X., Xing, M., Sun, S., Shi, Y., Wang, Y., Fang, J., & Yang, Y. (2026). Transcutaneous auricular vagus nerve stimulation improves depressive-like behaviors in CUMS rats through regulation of gut microbiome, serum metabolites, and immune factors. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1820578
Vancouver
Tan C, Qiao M, Ma Y, Wang X, Xing M, Sun S, et al. Transcutaneous auricular vagus nerve stimulation improves depressive-like behaviors in CUMS rats through regulation of gut microbiome, serum metabolites, and immune factors. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1820578
BibTeX
@article{Tan2026,
author = {Tan, Chaoren and Qiao, Meng and Ma, Yue and Wang, Xiaoling and Xing, Min and Sun, Shiyue and Shi, Yinan and Wang, Yingying and Fang, Jiliang and Yang, Yongsheng},
title = {Transcutaneous auricular vagus nerve stimulation improves depressive-like behaviors in CUMS rats through regulation of gut microbiome, serum metabolites, and immune factors},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1820578}
}
EUVIMED